Cisco gains on Q3 earnings beat and above-consensus Q4 guidance, MasterCard sees some spending normalization Check out this evening's top movers from around Wall Street, compiled by The Fly.
UP AFTER EARNINGS
-
- Arcadia Biosciences (RKDA) up 13.9%
- Jakks Pacific (JAKK) up 13.3%
- Revolve Group (RVLV) up 12.7%
- BRP Group (BRP) up 9.9%
- Cisco (CSCO) up 2.5%
- Flowers Food (FLO) up 2.5%
- Oceaneering (OII) up 2.4%
ALSO HIGHER
-
- Immunic (IMUX) up 33.8% after ph.2 trial of IMU-838 in COVID-19 patients got approval in Germany
- Allogene (ALLO) up 27.2% after reporting ALLO-501 data
in relapsed/refractory non-Hodgkin lymphoma
- ImmunoGen (IMGN) up 4.2% after disclosing initial data from FORWARD II study
- Mastercard (MA) up 2.4% after disclosing transition from stabilization phase to normalization phase in some markets
- Fiat Chrysler (FCAU) up 2.3% after suspending dividend and announcing Peugeot merger talks advancing well
DOWN AFTER EARNINGS
-
- Pangaea (PANL) down 11.2%
- 1Life Healthcare (ONEM) down 7.7%
- Virtusa (VRTU) down 5.5%
- Jack in the Box (JACK) down 3.7%
- SmileDirectClub (SDC) down 1.6%
ALSO LOWER -
- Arvinas (ARVN) down 18.6% after updated Phase 1 efficacy data for ARV-110
- Kiniksa (KNSA) down 7.3% after equity offering
Symbols:
KNSA ARVN SDC JACK VRTU ONEM PANL FCAU MA IMGN ALLO IMUX OII FLO CSCO RVLV BRP JAKK - $0.59 /
-0.0939 (-13.81%)
RKDA Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, mastercard, cisco